Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy of Oral Miltefosine in Patients With Post Kala Azar Dermal Leishmaniasis (PKDL)

This study has been completed.
Sponsor:
Collaborator:
World Health Organization
Information provided by (Responsible Party):
AB Foundation
ClinicalTrials.gov Identifier:
NCT01635777
First received: July 3, 2012
Last updated: July 9, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)